Literature DB >> 28384452

Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient.

Enrico N De Toni1, Alexander L Gerbes1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28384452     DOI： 10.1053/j.gastro.2017.01.063

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  20 in total

Review 1.  Liver graft rejection following immune checkpoint inhibitors treatment: a review.

Authors:  Bo Hu; Xiao-Bo Yang; Xin-Ting Sang
Journal:  Med Oncol       Date:  2019-10-11       Impact factor: 3.064

2.  The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.

Authors:  Ioannis A Ziogas; Alexandros P Evangeliou; Lipika Goyal; Georgios Tsoulfas; Dimitrios Giannis; Muhammad H Hayat; Konstantinos S Mylonas; Samer Tohme; David A Geller; Nahel Elias
Journal:  Oncologist       Date:  2021-01-02

3.  Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.

Authors:  Chimaobi M Anugwom; Thomas M Leventhal; Jose D Debes
Journal:  Hepatoma Res       Date:  2022-02-11

Review 4.  Cutaneous squamous cell carcinoma in the organ transplant recipient.

Authors:  Kristin Bibee; Andrew Swartz; Shaum Sridharan; Cornelius H L Kurten; Charles B Wessel; Heath Skinner; Dan P Zandberg
Journal:  Oral Oncol       Date:  2020-02-14       Impact factor: 5.337

5.  Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic Review.

Authors:  Kang Miao; Li Zhang
Journal:  Interdiscip Sci       Date:  2021-06-21       Impact factor: 2.233

6.  The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.

Authors:  Vivek Kumar; Atul B Shinagare; Helmut G Rennke; Sandeep Ghai; Jochen H Lorch; Patrick A Ott; Osama E Rahma
Journal:  Oncologist       Date:  2020-02-11

Review 7.  Use of checkpoint inhibitors in liver transplant recipients.

Authors:  Stefan Munker; Enrico N De Toni
Journal:  United European Gastroenterol J       Date:  2018-04-30       Impact factor: 4.623

8.  Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.

Authors:  Thomas T DeLeon; Marcela A Salomao; Bashar A Aqel; Mohamad B Sonbol; Raquel T Yokoda; Ahmad H Ali; Adyr A Moss; Amit K Mathur; David M Chascsa; Jorge Rakela; Alan H Bryce; Mitesh J Borad
Journal:  J Gastrointest Oncol       Date:  2018-12

9.  Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Authors:  Zi-Yun Qiao; Zi-Jie Zhang; Zi-Cheng Lv; Huan Tong; Zhi-Feng Xi; Hao-Xiang Wu; Xiao-Song Chen; Lei Xia; Hao Feng; Jian-Jun Zhang; Qiang Xia
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 7.561

10.  Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.

Authors:  Dimitri Gassmann; Stefan Weiler; Joachim C Mertens; Cäcilia S Reiner; Bart Vrugt; Mirjam Nägeli; Joanna Mangana; Beat Müllhaupt; Fabienne Jenni; Benjamin Misselwitz
Journal:  Transplant Direct       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.